Alasdair Thong
Fondatore presso Selvedge Innovation LLP
Provenienza dei contatti di primo grado di Alasdair Thong
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.
25
| Private Company | Investment Managers | 25 |
20
| Public Company | Pharmaceuticals: Major | 20 |
Selvedge Innovation LLP
 Selvedge Innovation LLP Investment ManagersFinance Selvedge Innovation LLP (Selvedge Venture) is a venture capital firm founded in 2019 by Alasdair Thong and Robert Thong. The firm is headquartered in London, United Kingdom.
8
| Private Company | Investment Managers | 8 |
Luminous Ventures Ltd.
 Luminous Ventures Ltd. Investment ManagersFinance Luminous Ventures Ltd. (Luminous Ventures) is an Independent Private Equity/Venture Capital firm founded in 2018 by Lomax Blois. The firm is headquartered in London.
6
| Private Company | Investment Managers | 6 |
Ada Ventures LLP
 Ada Ventures LLP Investment ManagersFinance Ada Ventures LLP (Ada Ventures) is a venture capital firm founded in 2018. The firm was founded in 2018. The firm is headquartered in London, UK.
4
| Private Company | Investment Managers | 4 |
Curiosity Edtech Pte Ltd.
 Curiosity Edtech Pte Ltd. Internet Software/ServicesTechnology Services Curiosity Edtech Pte Ltd. is the Indian company behind CuriousJr, an online coding platform for kids. The company is based in Gurgaon, India. The platform offers an effective curriculum and practice modules to teach coding, which is considered an essential skill for the future. The company was founded by IITians with the aim of helping kids acquire future skills.
4
| Holding Company | Internet Software/Services | 4 |
Multiomic Health Ltd.
 Multiomic Health Ltd. BiotechnologyHealth Technology Multiomic Health Ltd. is a British AI-enabled drug discovery company that focuses on chronic multi-factorial diseases, particularly metabolic syndrome-related conditions. Multiomic Health is based in London, UK. The company partners with research institutions, healthcare providers, and healthtech companies to source de-identified patient data and samples. Multiomic's MOHSAIC® platform combines integrated multi-omics analysis and computational systems biology modeling with targeted wet laboratory experiments to originate novel precision therapeutic concepts. The company subsequently partners with established biopharma companies to take its therapeutic concepts into clinical trial programs and market the ensuing medicines. The company was founded in 2021 by Robert Vee-Lin Thong and Alasdair Thong, and Robert Vee-Lin Thong has been the CEO since 2021.
3
| Holding Company | Biotechnology | 3 |
Ochre Bio Ltd.
 Ochre Bio Ltd. Pharmaceuticals: MajorHealth Technology Ochre Bio Ltd. is a biotechnology company based in Headington, UK. Ochre Bio is focused on developing RNA medicines for chronic liver diseases. The British company uses deep phenotyping, precision RNA medicine, and testing in live human donor livers to develop therapies for important liver health challenges. The company's goal is to develop therapies that increase donor liver supply and reduce cirrhosis complications. The company was founded by Quin Wills and the CEO is Jack O'Meara.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Exogene Ltd.
 Exogene Ltd. Packaged SoftwareTechnology Services Exogene Ltd. develops an artificial intelligence machine learning platform to discover cell therapies for cancer immunotherapies. The company is based in Oxford, UK. The British company was founded by Andrea Mambrini and Federico Paoletti, with Federico Paoletti serving as CEO since incorporation.
2
| Holding Company | Packaged Software | 2 |
KdT Ventures LLC
 KdT Ventures LLC Investment ManagersFinance KdT Ventures LLC (KdT Ventures) is a venture capital firm founded in 2017 by Cain Mcclary . The firm is headquartered in Austin, Texas.
1
| Private Company | Investment Managers | 1 |
Sanome
 Sanome BiotechnologyHealth Technology Part of Sanome Ltd, Sanome operates as a British biotechnology company that develops at-home health monitoring tools. The company is based in Cambridge, UK. The company was founded by Benedikt von Thüngen, Marc Philippe Camille van der Schee. Benedikt von Thüngen has been the CEO since incorporation.
1
| Subsidiary | Biotechnology | 1 |
Avro Life Science
 Avro Life Science Pharmaceuticals: MajorHealth Technology Avro Life Science develops skin patches for generic drug delivery. It focuses on children and adult therapeutics. The company was founded by Shakir Lakhani and Keean Sarani and is headquartered in Canada.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Alasdair Thong tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Analyst | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| LONZA GROUP AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BAYER CROPSCIENCE LIMITED | Chemicals: Agricultural | Director/Board Member Director/Board Member | |
| Imperial College London | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Founder Private Equity Analyst Private Equity Analyst Private Equity Investor Private Equity Analyst | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Masters Business Admin | |
| COVESTRO AG | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| Tufts University | College/University | Graduate Degree Undergraduate Degree | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
Stealthyx Therapeutics Ltd.
 Stealthyx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Stealthyx Therapeutics Ltd. operates drug delivery system technology. The company was founded by Yuti Chernajovsky and Eileen Janis Anderson in 2002 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Index Ventures (UK) LLP | Investment Managers | Private Equity Investor Private Equity Investor | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
XO1 Ltd.
 XO1 Ltd. Medical/Nursing ServicesHealth Services XO1 Ltd. develops a novel anticoagulant drug. The firm operates as a biopharmaceutical company. The company was founded by David J. Grainger on February 28, 2013 and is headquartered in High Wycombe, the United Kingdom. | Medical/Nursing Services | Founder Founder | |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
| Stx Pharma Ltd. | Director/Board Member Founder | ||
Covestro Deutschland AG
 Covestro Deutschland AG Chemicals: SpecialtyProcess Industries Covestro Deutschland AG engages in the production and distribution of polymers. It also sells paints and adhesive raw materials. The company was founded on April 8, 2002 and is headquartered in Leverkusen, Germany. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
Morphogen-IX Ltd.
 Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member Director/Board Member | |
Inhibitaxin Ltd.
 Inhibitaxin Ltd. BiotechnologyHealth Technology Inhibitaxin Ltd. engages in research and development on biotechnology. The company was founded by Simon Lempriere Westbrook and Kevin S. Johnson in 2013 and is headquartered in Kent, the United Kingodm. | Biotechnology | Founder Director/Board Member | |
Janpix Holdings, Inc.
 Janpix Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Janpix Holdings, Inc. engages in provision of research and experimental development on biotechnology. The company was founded by Patrick T. Gunning and Cortes Pierre and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Founder | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Impact Biomedicines, Inc.
 Impact Biomedicines, Inc. Medical SpecialtiesHealth Technology Impact Biomedicines, Inc. engages in the development of cancer treatments. It engages in the development of fedratinib, a potent and selective oral molecule JAK2 kinase inhibitor for the treatment of myelofibrosis and polycythemia vera. The company was founded by John Hood, Catriona Jamieson and Raghu Saripalli in 2016 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
UltraHuman Ltd.
 UltraHuman Ltd. Miscellaneous Commercial ServicesCommercial Services UltraHuman Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Sandwich, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Cambridge Cancer Genomics Ltd.
 Cambridge Cancer Genomics Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Cancer Genomics Ltd. provide cancer therapy. It also provides health care and diagnostics. The company is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
BIOS Health Ltd.
 BIOS Health Ltd. Medical SpecialtiesHealth Technology BIOS Health Ltd. develops a medical device that uses advanced bioengineering and monitoring technologies. The company was founded by Emil Hewage and Oliver Armitage and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Rebalance (Cambridge) Ltd.
 Rebalance (Cambridge) Ltd. Miscellaneous Commercial ServicesCommercial Services Rebalance (Cambridge) Ltd. provides research and experimental development on biotechnology. The company was founded on December 6, 2016 and is headquartered in Hatfield, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Human Antibody Factory Ltd.
 Human Antibody Factory Ltd. BiotechnologyHealth Technology Human Antibody Factory Ltd. provides research and experimental development on biotechnology. The company was founded by David John Grainger and is headquartered in Hatfield, the United Kingdom. | Biotechnology | Director/Board Member Founder | |
| MODERNA, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Kaerus Bioscience Ltd. | Chairman Director/Board Member | ||
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Director/Board Member | |
Neo Kuma Venture Partners LLP
 Neo Kuma Venture Partners LLP Investment ManagersFinance Neo Kuma Venture Partners LLP (Neo Kuma Venture) is a venture capital firm founded in 2020. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member Director/Board Member | |
| DANUBE AG | Chemicals: Specialty | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Regno Unito | 24 |
| Stati Uniti | 17 |
| Svizzera | 5 |
| Germania | 4 |
| Paesi Bassi | 3 |
Settori
| Health Technology | 29 |
| Finance | 7 |
| Commercial Services | 7 |
| Process Industries | 5 |
| Consumer Services | 4 |
Posizioni
| Director/Board Member | 334 |
| Corporate Officer/Principal | 110 |
| Founder | 77 |
| Chairman | 72 |
| Chief Executive Officer | 64 |
Contatti più connessi
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Francesco de Rubertis | 36 |
| Eliot Forster | 35 |
| Thomas Ebeling | 33 |
| Michèle Ollier | 33 |
| Dieter Weinand | 32 |
| David Grainger | 29 |
| Giuseppe Zocco | 26 |
| Jak Knowles | 24 |
| Erica L. Mann | 23 |
| Kevin Johnson | 22 |
| Sanford Zweifach | 22 |
| Moncef Slaoui | 22 |
| Aaron Kantoff | 19 |
| Edward Zimmerman | 17 |
- Borsa valori
- Insiders
- Alasdair Thong
- Connessioni Società
